Market Outlook

By 2035, the U.S. Digital Diagnostic Imaging Devices Market is expected to reach approximately USD 28.63 billion, expanding at a CAGR of 6.75% during the forecast period 2026-2035. The market was valued at USD 14.90 billion in 2025, with historical analysis from 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. digital diagnostic imaging devices industry is a capital-intensive but structurally resilient segment of the medical technology market. It includes digital radiography, computed tomography, magnetic resonance imaging, diagnostic ultrasound, digital mammography, and nuclear or hybrid imaging systems used to identify, characterize, stage, and monitor disease. The market is supported by a large installed base, recurring replacement cycles, sustained imaging utilization, high chronic disease prevalence, and the strategic importance of radiology to emergency, oncology, cardiovascular, neurological, orthopedic, and women’s health workflows.

Demand is increasingly moving away from stand-alone scanners toward connected imaging platforms that combine high-performance detectors, advanced reconstruction, automation, dose management, remote service, cybersecurity, and artificial intelligence. U.S. health systems are evaluating imaging purchases through total operating economics rather than scanner price alone. Systems that shorten protocols, increase exams per shift, reduce repeat scans, support lower radiation or contrast use, simplify technologist tasks, and integrate with enterprise image management are receiving stronger procurement attention.

The historical market expanded from an estimated USD 11.28 billion in 2021 to USD 13.84 billion in 2024. Growth reflected recovery in deferred capital spending, renewed screening activity, expansion of outpatient imaging networks, hospital modernization programs, and accelerated adoption of digital breast tomosynthesis, high-slice CT, wide-bore MRI, portable ultrasound, and AI-enabled reconstruction. The market reached USD 14.90 billion in 2025 as large health systems resumed multi-year fleet replacement plans and independent imaging providers invested in capacity, automation, and lower-cost operating models.

The revenue model covers new digital imaging equipment, major system upgrades, device-integrated software and AI sold with the platform, and modality-specific accessories that are essential to system operation. It excludes stand-alone PACS, general-purpose enterprise software, maintenance contracts, contrast media, imaging services, and most refurbished equipment. This boundary is important because the U.S. imaging ecosystem generates substantially more economic value than equipment revenue alone, but combining service, software, consumables, and capital equipment would overstate the addressable device market.

Introduction

According to the U.S. Digital Diagnostic Imaging Devices Market Report, imaging is one of the most widely used diagnostic foundations in American healthcare. More than 80 million CT examinations and nearly 40 million MRI examinations are performed annually in the United States, while mammography facilities report more than 43 million procedures a year. These volumes illustrate why imaging equipment availability, uptime, throughput, and diagnostic confidence have direct consequences for hospital capacity, emergency department flow, cancer detection, surgical planning, and specialist productivity.

The U.S. market is supported by one of the world’s largest care-delivery infrastructures. The country has approximately 6,100 hospitals, more than 907,000 staffed beds, and over 35 million annual hospital admissions. Imaging devices are deployed across academic medical centers, community hospitals, freestanding diagnostic centers, physician offices, urgent care facilities, ambulatory surgery centers, emergency departments, mobile imaging fleets, and increasingly home- or community-oriented care models. The breadth of these settings creates demand for both premium fixed systems and compact, lower-cost devices.

The aging population is a major demand multiplier. The number of U.S. residents aged 65 and older reached approximately 61.2 million in 2024, rising by more than 13% from 2020. Older adults use imaging more frequently because of cancer, cardiovascular disease, neurodegenerative conditions, fractures, degenerative joint disease, chronic pulmonary disease, and complex multimorbidity. The result is a durable increase in CT, MRI, ultrasound, mammography, bone, and nuclear imaging needs even when individual modality prices face pressure.

Digital diagnostic imaging is also becoming a workflow market. Hospitals no longer purchase only image quality; they purchase scan capacity, staffing leverage, interoperability, clinical standardization, and lifecycle predictability. A scanner that reduces a protocol by several minutes can create meaningful annual capacity across a high-volume network. A reconstruction algorithm that lowers noise or motion artifacts can reduce repeat studies. Automated positioning and protocol selection can help less-experienced technologists achieve more consistent results. Remote operations can extend specialized expertise across multiple sites. These workflow benefits increasingly determine vendor selection.

From 2026 to 2035, the central strategic theme will be the conversion of imaging fleets into data-rich, software-defined diagnostic platforms. Hardware differentiation will remain critical, particularly in photon-counting CT, gradient performance, detector sensitivity, portable imaging, and molecular imaging. However, sustained value creation will depend on whether manufacturers can combine hardware with upgradeable software, AI orchestration, remote fleet management, cybersecurity, and evidence that the platform improves both clinical outcomes and operating margins.

Key Market Drivers: What’s Fueling the U.S. Digital Diagnostic Imaging Devices Market Boom?

The first major driver is the scale and persistence of chronic disease. The United States records more than 1.9 million invasive cancer diagnoses in a typical recent year, and cancer pathways depend heavily on CT, MRI, mammography, ultrasound, PET, SPECT, and image-guided biopsy. Cardiovascular disease, stroke, chronic lung disease, diabetes complications, kidney disease, and musculoskeletal disorders add large recurring imaging volumes. Screening guidelines also create repeat demand, including annual low-dose CT for eligible high-risk adults and routine breast imaging across a large female population.

A second driver is rising imaging utilization relative to workforce capacity. A multi-practice U.S. analysis covering 46.4 million examinations found that imaging volume increased 31% from early 2018 to early 2024, while the radiologist workforce in the sample grew 24%. This imbalance supports investment in faster scanners, automated protocols, AI triage, reconstruction, structured workflow, remote reading, and enterprise standardization. Procurement teams increasingly treat imaging technology as a workforce productivity tool, not simply a diagnostic asset.

A third driver is the replacement of aging installed equipment. CT, MRI, radiography, mammography, and nuclear imaging systems have long useful lives, but the clinical and economic penalty of extending equipment beyond an optimal cycle can become substantial. Older systems may have slower acquisition, higher service costs, lower detector efficiency, weaker cybersecurity, limited software support, less automation, and difficulty meeting current image quality or dose expectations. U.S. health systems are therefore adopting fleet-level replacement strategies that prioritize the most constrained sites and standardize platforms across networks.

A fourth driver is the migration of diagnostics toward outpatient and distributed care. Freestanding imaging centers, orthopedic practices, cardiology groups, oncology networks, urgent care operators, and ambulatory facilities are adding imaging capacity to reduce referrals, capture professional and technical revenue, and improve patient convenience. This shift favors compact CT, open or wide-bore MRI, digital radiography, cone-beam CT, office-based ultrasound, mobile C-arms, and portable devices. Manufacturers that can provide lower site-preparation costs, simplified operation, and predictable service economics are positioned to gain share.

A fifth driver is hospital capital procurement behavior. Radiology is a shared service line that supports nearly every high-value clinical department. A modern CT scanner can influence emergency throughput, stroke activation, trauma care, oncology staging, cardiac imaging, and surgical planning. MRI capacity affects neurology, orthopedics, oncology, pediatrics, and women’s health. Because imaging bottlenecks can delay discharges and procedures, capital committees increasingly evaluate scanner purchases through contribution margin, referral retention, avoided outsourcing, technician staffing, uptime, and patient access.

A sixth driver is the expansion of AI-enabled imaging. Radiology represents the largest category in the FDA’s public list of AI-enabled medical devices. AI is being embedded into acquisition, reconstruction, positioning, image quality control, triage, quantification, lesion detection, workflow routing, and reporting support. The most commercially valuable applications are those that are native to the scanner or deeply integrated into workflow, because they reduce implementation friction and can be measured through exam time, callback reduction, reading efficiency, or improved consistency.

A seventh driver is regulatory and reimbursement alignment around appropriate imaging. Medicare’s advanced diagnostic imaging framework specifically covers CT, MRI, PET, and nuclear medicine, reinforcing the importance of medical necessity, documentation, and appropriate-use controls. At the same time, screening coverage, hospital outpatient payment, physician fee schedules, and commercial payer policies shape modality demand. Manufacturers that help providers standardize protocols, document quality, and support reimbursable pathways are more likely to protect premium positioning.

An eighth driver is patient preference for faster, less invasive, and more accessible diagnosis. Wide-bore MRI, shorter scan sequences, lower-dose CT, quieter systems, breast tomosynthesis, handheld ultrasound, and mobile radiography improve the patient experience while expanding operational capacity. Consumer expectations are particularly relevant in competitive metropolitan markets where patients can choose among hospital-owned and independent imaging providers. Systems that reduce claustrophobia, waiting time, repeat appointments, and travel burden can improve both patient satisfaction and referral loyalty.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. digital diagnostic imaging devices market is increasingly directed toward spectral information, speed, automation, sustainability, and clinical specificity. The next competitive cycle will not be defined only by higher spatial resolution. It will be defined by the ability to produce diagnostically useful information with less dose, less contrast, less scan time, fewer operator-dependent steps, and stronger integration into the care pathway.

Photon-counting CT is one of the most important platform shifts. Unlike conventional energy-integrating detectors, photon-counting detectors can capture more detailed information about individual X-ray photons and support improved spatial resolution, spectral differentiation, and dose efficiency. The technology is initially concentrated in high-acuity academic and tertiary centers because of premium pricing and advanced clinical use cases. Over the forecast period, broader system availability and additional clinical evidence are expected to move photon-counting capabilities into larger regional health systems and selected outpatient networks.

MRI innovation is focused on faster acquisition, stronger gradients, AI reconstruction, wider bores, reduced helium dependence, and specialized systems. Advanced neuroimaging, cardiac MRI, prostate imaging, musculoskeletal protocols, and oncology applications support demand for premium 3.0T platforms, while lower-field and open systems improve access for patients with claustrophobia, obesity, implants, or point-of-care needs. Helium-light or virtually helium-free magnet designs also improve installation flexibility and reduce exposure to supply and service risk.

Digital radiography is evolving through wireless detectors, automated positioning, dose optimization, mobile workflow, and image-quality analytics. The segment is mature, but its very large installed base creates recurring replacement and retrofit demand. Emergency departments, intensive care units, operating rooms, nursing facilities, and rural hospitals value mobile digital radiography because it can bring imaging to patients who are difficult to transport. Detector sharing, battery performance, ruggedness, infection-control design, and seamless image transfer are increasingly important purchase criteria.

Ultrasound innovation is centered on portability, miniaturization, AI-guided acquisition, automated measurement, elastography, contrast-enhanced imaging, and cloud connectivity. Handheld ultrasound is expanding beyond radiology into emergency medicine, critical care, cardiology, obstetrics, anesthesia, primary care, and procedural guidance. The commercial challenge is no longer whether a handheld device can produce an image; it is whether it can support reproducible acquisition, credentialing, documentation, billing, and integration with the patient record.

Breast imaging is moving toward digital breast tomosynthesis, synthetic 2D imaging, AI-assisted detection, automated density assessment, contrast-enhanced mammography, and more personalized screening pathways. U.S. mammography infrastructure is extensive, with roughly 9,000 certified facilities and more than 26,000 accredited units. Tomosynthesis now represents a large share of the installed base, creating demand for replacement platforms, AI upgrades, improved workflow, and integration of risk information. The federal breast-density notification requirement has also increased attention to supplemental imaging and patient communication.

Nuclear and hybrid imaging innovation is being shaped by digital PET detectors, time-of-flight performance, total-body or extended axial field-of-view systems, quantitative imaging, and the growth of theranostics. Oncology remains the main demand center, but cardiology and neurology applications are also important. The economics of PET/CT and SPECT/CT depend heavily on throughput, radiopharmaceutical logistics, reimbursement, and referral volume. Systems that reduce scan time or radiotracer dose can materially improve capacity and operating economics.

Manufacturers are also raising the bar through lifecycle design. Subscription-based software upgrades, remote monitoring, predictive maintenance, cybersecurity support, and fleet analytics are becoming part of the capital proposition. Large integrated delivery networks increasingly prefer vendors that can standardize protocols across sites, provide centralized performance visibility, and upgrade installed systems without full replacement. This favors companies with broad modality portfolios, strong service organizations, and software architectures designed for repeated enhancement.

Segmentation Insights

The U.S. Digital Diagnostic Imaging Devices Market is segmented on the basis of modality, technology and configuration, application, end user, and region.

By Modality

• Digital X-ray and radiography systems represent the largest category by installed unit volume. The segment includes fixed digital radiography rooms, mobile radiography systems, fluoroscopy-capable platforms, retrofit detectors, and compact systems used in urgent care, orthopedics, emergency medicine, and bedside imaging. Revenue growth is moderate because the category is mature, but the replacement pool is large. Wireless detectors, automated positioning, dose analytics, and mobile workflow are the principal value differentiators.
• Computed tomography systems account for an estimated 26% of 2025 market revenue and remain one of the most strategically important capital categories. CT is indispensable in trauma, stroke, pulmonary care, oncology, cardiac assessment, emergency diagnosis, and surgical planning. Demand is moving toward higher-slice configurations, wide detectors, spectral imaging, cardiac capability, automated workflow, and lower-dose reconstruction. Photon-counting CT will be the highest-growth premium subsegment, although conventional high-performance CT will continue to dominate placements through most of the forecast period.
• Magnetic resonance imaging systems account for approximately 24% of 2025 revenue. The segment includes 1.5T and 3.0T whole-body systems, open MRI, dedicated extremity or neurological systems, and emerging point-of-care platforms. MRI has favorable long-term growth because it avoids ionizing radiation and provides strong soft-tissue characterization. Constraints include high installation cost, long scan times, technologist requirements, magnet siting, and patient tolerance. AI acceleration and low-helium designs are improving the economic case for replacement.
• Diagnostic ultrasound systems include cart-based, compact, portable, and handheld devices. Ultrasound is used across radiology, obstetrics and gynecology, cardiology, emergency medicine, critical care, anesthesia, vascular medicine, and primary care. The segment benefits from low infrastructure requirements and the ability to perform real-time imaging at the point of care. Premium cart-based systems remain important for complex diagnostic studies, while handheld devices are expanding the addressable user base and creating new recurring software models.
• Digital mammography and breast imaging systems include 2D digital mammography, digital breast tomosynthesis, breast ultrasound, contrast-enhanced mammography, and selected dedicated breast imaging platforms. More than 43 million mammography procedures are reported annually in the U.S., supporting a significant replacement and upgrade market. Demand is strongest for tomosynthesis, AI-assisted reading, density assessment, faster acquisition, and technologies that improve performance in dense breasts or reduce recalls.
• Nuclear medicine and hybrid imaging systems include PET, PET/CT, SPECT, SPECT/CT, and selected PET/MR platforms. The category has a smaller installed base but high average selling prices and growing strategic importance in oncology and theranostics. Digital detector technology, faster acquisition, quantitative imaging, and improved sensitivity are expanding clinical utility. Market growth is constrained by capital cost, radiopharmaceutical availability, and specialized staffing, but high-volume cancer centers and academic institutions continue to invest.

By Technology and Configuration

• Fixed high-acuity imaging platforms dominate market value. These systems include premium CT, MRI, PET/CT, SPECT/CT, fluoroscopy, mammography, and digital radiography rooms installed in hospitals and major imaging centers. Buyers prioritize image quality, throughput, uptime, service coverage, advanced applications, and integration with enterprise workflows. Fixed platforms will remain the core revenue base, but growth will increasingly depend on software upgradeability and the ability to support multiple clinical service lines.
• Mobile and portable systems are the fastest-growing configuration category. Mobile radiography, compact ultrasound, portable CT, mobile C-arms, and deployable imaging units reduce patient transport and support emergency, critical care, perioperative, rural, and post-acute workflows. The strongest products combine acceptable diagnostic performance with simple setup, battery reliability, secure connectivity, and durable infection-control design. Hospitals also value mobile systems as surge capacity and as backup during fixed-system downtime.
• Handheld and point-of-care imaging devices are expanding the market beyond traditional radiology departments. Handheld ultrasound is the primary subsegment, although compact optical and low-field imaging technologies are also emerging. Adoption is strongest when devices are paired with AI guidance, standardized protocols, secure image storage, and training programs. The long-term opportunity is substantial, but reimbursement, credentialing, governance, and image quality assurance will determine whether use becomes routine or remains episodic.
• AI-enabled and software-defined imaging systems represent a cross-modality premium layer. These platforms use deep learning or advanced algorithms for acquisition planning, reconstruction, motion correction, dose optimization, image quality control, automated measurements, triage, and clinical decision support. In 2025, AI was more commonly purchased as part of a broader platform or enterprise agreement than as a fully autonomous diagnostic tool. The strongest growth will come from embedded applications with clear operational value and low implementation burden.
• Hybrid and multimodality systems combine anatomical, functional, or procedural information. PET/CT, SPECT/CT, PET/MR, spectral CT, fusion ultrasound, and cone-beam imaging integrated with procedural platforms fall within this category. Hybrid systems command premium prices because they can consolidate diagnostic information and support complex oncology, cardiology, neurology, and image-guided workflows. Their adoption is concentrated in high-volume centers that can justify the capital through referral density and specialized clinical programs.

By Application

• Oncology is the largest application segment because imaging is required across screening, diagnosis, staging, treatment planning, response assessment, surveillance, and recurrence detection. CT and MRI provide anatomical characterization, PET and SPECT add functional information, mammography supports breast screening, and ultrasound guides biopsy and surveillance. The high incidence of cancer and the expansion of precision oncology support demand for quantitative imaging, theranostics, advanced reconstruction, and standardized longitudinal comparison.
• Cardiovascular imaging is a high-value application supported by coronary artery disease, structural heart disease, heart failure, peripheral vascular disease, and congenital conditions. CT is gaining importance in coronary assessment and procedural planning, while MRI provides tissue characterization and functional evaluation. Echocardiography remains one of the most frequently used cardiac imaging tools. Hospitals are prioritizing platforms that integrate imaging with intervention, reduce contrast or radiation exposure, and improve reproducibility across operators.
• Neurology and neurovascular imaging rely heavily on CT and MRI for stroke, trauma, tumors, epilepsy, neurodegeneration, multiple sclerosis, and spine disease. Time-sensitive stroke pathways create strong demand for rapid CT acquisition, perfusion capability, automated triage, and reliable 24-hour operation. Advanced MRI supports diffusion, functional, spectroscopy, and biomarker research. Dedicated neuroimaging systems and AI-based quantification are expected to gain adoption in academic centers and specialized neurological networks.
• Orthopedic and musculoskeletal imaging includes radiography, MRI, ultrasound, cone-beam CT, and selected nuclear imaging. The segment is supported by sports injuries, degenerative joint disease, spine disorders, fractures, and preoperative planning. Orthopedic groups and ambulatory centers increasingly invest in in-office imaging to retain referrals and accelerate treatment decisions. Compact MRI, weight-bearing CT, digital radiography, and point-of-care ultrasound are particularly relevant to decentralized care models.
• Women’s health imaging is driven by breast screening, gynecological assessment, obstetric ultrasound, bone health, and pelvic imaging. Mammography remains the largest device category within this application, with digital breast tomosynthesis representing the dominant innovation cycle. The combination of breast-density notification, risk-based screening, AI assistance, and supplemental ultrasound or MRI is creating a more complex diagnostic pathway and supporting investment in integrated breast imaging platforms.
• Pulmonary, emergency, and abdominal imaging form a broad high-volume application base. Chest radiography, CT, ultrasound, and MRI are used for respiratory disease, infection, trauma, acute abdominal pain, kidney and liver disorders, and emergency triage. Low-dose CT screening eligibility for high-risk smokers creates an additional recurring pathway. Hospitals value rapid protocols, automated positioning, fast reconstruction, and mobile imaging because these functions directly affect emergency department length of stay and inpatient flow.

By End User

• Hospitals and integrated health systems are the dominant end users and account for the majority of high-value CT, MRI, nuclear imaging, fixed radiography, and enterprise mammography purchases. Large systems increasingly negotiate multi-modality fleet agreements, standardize vendors, and use centralized capital planning. Their value analysis committees evaluate clinical differentiation, total cost of ownership, cybersecurity, service responsiveness, training, interoperability, and the ability to scale protocols across multiple facilities.
• Academic medical centers and tertiary referral hospitals are the primary adopters of photon-counting CT, high-performance 3.0T MRI, advanced PET, research-grade neuroimaging, spectral technologies, and complex AI applications. These institutions generate clinical evidence, train specialists, and influence national adoption. They are willing to pay premium prices when technology supports research, complex case referral, or competitive differentiation, but procurement still requires strong uptime, service, and lifecycle commitments.
• Freestanding diagnostic imaging centers are a major commercial segment because they compete on access, convenience, scheduling, and cost. These operators often maintain high scanner utilization and are highly sensitive to throughput, payer mix, site-of-service reimbursement, and lease or financing terms. They favor systems with efficient protocols, lower construction requirements, remote service, and dependable operating costs. Consolidation among imaging-center networks is strengthening enterprise purchasing power.
• Ambulatory, specialty, and physician-office settings include orthopedic clinics, cardiology practices, women’s health centers, oncology groups, urgent care facilities, and ambulatory surgery centers. Demand is strongest for digital radiography, ultrasound, cone-beam CT, compact MRI, mobile C-arms, and dedicated imaging systems. Equipment must fit smaller spaces, require limited staffing, and generate enough procedure volume to support the investment. Ease of use and reimbursement support are particularly important.
• Emergency, rural, mobile, and community-based providers represent a smaller but strategically important end-user group. Rural hospitals and critical access facilities face capital constraints, staffing shortages, and long travel distances for patients. Mobile radiography, portable ultrasound, lower-cost CT, remote operation, and shared mobile imaging services can improve access. Federal and state infrastructure funding, rural health initiatives, and tele-radiology integration will influence growth in this segment.

Regional Insights: Where the Market is Growing Fastest

The U.S. Digital Diagnostic Imaging Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs based on population growth, age mix, hospital density, cancer and chronic disease burden, academic medical center concentration, outpatient imaging penetration, rural access, payer mix, and capital availability. The South is the largest regional market in 2025, while the West is projected to record the fastest CAGR through 2035. The Northeast remains the highest-acuity and most research-intensive region, and the Midwest provides a stable installed base with substantial replacement demand.

South

The South accounted for an estimated USD 5.07 billion in 2025, representing about 34% of the national market. It includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, the District of Columbia, Tennessee, Kentucky, Alabama, Mississippi, Arkansas, Louisiana, and Oklahoma. The region leads because it combines large and fast-growing populations, a high chronic disease burden, strong hospital construction, major urban referral hubs, and a substantial Medicare population.

Texas is one of the largest state markets, supported by major health systems and academic centers in Houston, Dallas-Fort Worth, Austin, San Antonio, and other metropolitan areas. Population expansion and continued investment in emergency, oncology, cardiovascular, and ambulatory capacity sustain demand for CT, MRI, ultrasound, and digital radiography. The state also has a large rural footprint, creating a parallel market for portable systems, mobile services, and remote operational support.

Florida is a critical imaging market because of its large older population, high concentration of Medicare beneficiaries, and extensive outpatient diagnostic infrastructure. Demand is particularly strong for oncology imaging, mammography, cardiac imaging, musculoskeletal MRI, and emergency CT. Imaging-center competition encourages investment in wide-bore MRI, fast CT, tomosynthesis, and patient-friendly scheduling. Hurricane exposure and geographic dispersion also increase the value of resilient service networks and mobile capacity.

North Carolina, Georgia, Virginia, Maryland, Tennessee, and South Carolina are growth markets with expanding metropolitan populations and sophisticated provider systems. North Carolina benefits from academic centers and life-sciences activity in the Research Triangle and major health systems across Charlotte and Winston-Salem. Georgia’s growth is concentrated around Atlanta and regional hospital networks. Virginia and Maryland combine large suburban populations with academic, federal, military, and integrated-delivery infrastructure. Tennessee has strong hospital and outpatient networks centered on Nashville, Memphis, and Knoxville.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have significant chronic disease and rural-access needs. These states are important for CT, radiography, ultrasound, and mobile imaging, but capital availability and specialist shortages can slow premium adoption outside major cities. Manufacturers can succeed through scalable configurations, financing, service coverage, and remote workflow support. Regional referral centers remain attractive for high-end oncology, neuro, and cardiovascular platforms.

Delaware and the District of Columbia are small by population but strategically relevant because of dense healthcare utilization and proximity to major Mid-Atlantic systems. Their demand is shaped more by hospital complexity and cross-state referral patterns than by local population alone. Across the South, health-system consolidation is increasing the importance of enterprise contracts, fleet standardization, and vendor ability to serve both urban flagship hospitals and smaller community sites.

The South is projected to reach approximately USD 9.75 billion by 2035, advancing at about 6.76% annually. Growth will be supported by population migration, hospital and outpatient capacity expansion, aging demographics, replacement of legacy equipment, and continued investment in cancer, cardiac, emergency, and women’s health services. Texas and Florida will remain the anchor markets, while North Carolina, Georgia, Virginia, Tennessee, and South Carolina are expected to gain share.

West

The West represented an estimated USD 3.55 billion in 2025 and is expected to be the fastest-growing region, reaching approximately USD 7.62 billion by 2035 at a CAGR of about 7.94%. The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii. Growth is supported by technology-oriented health systems, population expansion in the Mountain West, early adoption of AI, and strong demand for distributed imaging across large geographic areas.

California is the largest state market in the West and one of the largest nationally. It has a dense concentration of academic medical centers, integrated delivery networks, cancer centers, imaging chains, and medtech innovators. The state is an early market for photon-counting CT, advanced MRI, digital PET, AI-enabled workflow, and cloud-connected imaging. Large systems also place strong emphasis on sustainability, energy consumption, helium reduction, cybersecurity, and enterprise interoperability.

Washington and Oregon have sophisticated health systems, strong digital-health adoption, and significant urban-rural access differences. Seattle and Portland support premium imaging demand, while remote communities create opportunities for portable ultrasound, mobile radiography, tele-radiology, and regional fleet management. Health systems in these states often prioritize standardized protocols, dose management, and data-sharing across wide networks.

Arizona and Nevada are among the most attractive growth states because of rapid population expansion, retiree migration, and rising investment in hospitals, ambulatory centers, and specialty care. Phoenix, Tucson, Las Vegas, and Reno are expanding imaging capacity for oncology, orthopedics, cardiovascular care, and emergency medicine. Wide-bore MRI, high-throughput CT, mammography, and outpatient ultrasound are particularly important. Heat, distance, and service logistics also influence equipment design and vendor selection.

Colorado and Utah combine population growth with research-oriented and integrated provider systems. Denver, Colorado Springs, Salt Lake City, and Provo are important regional hubs. These markets are receptive to advanced MRI, cardiac imaging, AI workflow, portable ultrasound, and sports medicine applications. Utah’s younger population moderates age-driven demand, but rapid growth and strong health-system investment support long-term equipment expansion.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller state markets but have high access complexity. Low population density, long travel distances, and limited specialist availability increase the value of mobile, portable, and remotely supported imaging. Alaska and Hawaii face especially demanding logistics and service economics. Idaho and Montana are benefiting from population growth in selected metropolitan areas, while New Mexico has substantial rural and tribal healthcare needs.

The West’s strategic importance extends beyond regional revenue. It is a test market for software-defined imaging, AI deployment, alternative outpatient models, and partnerships between device companies, digital-health firms, and academic centers. Manufacturers that can prove workflow value in California and scale lower-infrastructure solutions across the Mountain West are likely to strengthen national competitive positioning.

Northeast

The Northeast accounted for an estimated USD 3.61 billion in 2025 and is projected to reach approximately USD 6.63 billion by 2035. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, and Maine. Its market strength is driven by high hospital density, advanced academic institutions, specialist concentration, mature screening infrastructure, and a large installed base of premium imaging equipment.

New York is the largest state market in the Northeast. New York City contains major academic systems, cancer centers, and high-volume outpatient imaging networks, while upstate markets depend on regional referral centers and community hospitals. The state supports demand across all modalities, including high-end CT, MRI, PET/CT, mammography, radiography, and ultrasound. Procurement is evidence-driven and often tied to enterprise integration, throughput, and replacement of expensive urban assets.

Pennsylvania and New Jersey form a large Mid-Atlantic imaging corridor. Philadelphia, Pittsburgh, northern New Jersey, and central New Jersey contain strong health systems, research institutions, and independent imaging operators. Dense populations and cross-state referral patterns support high utilization. These states are important for oncology, neurological, cardiovascular, orthopedic, and women’s health imaging, with ongoing demand for fleet modernization and outpatient capacity.

Massachusetts is disproportionately influential because of its concentration of academic medical centers, biomedical research, and early-stage technology evaluation. Boston-area institutions are frequent adopters of advanced neuroimaging, photon-counting CT, quantitative MRI, PET, and imaging AI. Although the state’s population is smaller than New York or Pennsylvania, its procedure complexity and research intensity produce high equipment value per site.

Connecticut and Rhode Island have mature provider networks and high imaging utilization. Their growth will be driven mainly by replacement, consolidation, and upgrades rather than greenfield expansion. Vermont, New Hampshire, and Maine are smaller markets with older populations and meaningful rural-access needs. These states require a balance of premium imaging at regional centers and cost-efficient, reliable systems at community hospitals.

The Northeast is expected to grow at approximately 6.27% annually through 2035. Growth is slightly below the West and South because population expansion is slower and the installed base is mature. However, the region will remain one of the most profitable markets for advanced systems because of procedure complexity, research activity, high specialist density, and early adoption of premium technologies. Vendors must compete on evidence, cybersecurity, enterprise integration, and service performance rather than price alone.

Midwest

The Midwest represented an estimated USD 2.67 billion in 2025 and is expected to reach approximately USD 4.63 billion by 2035, reflecting a CAGR of about 5.66%. The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota. Demand is supported by established hospital networks, strong regional referral systems, an aging installed base, and significant chronic disease burden across both urban and rural populations.

Illinois, Ohio, Michigan, and Minnesota are the principal state markets. Chicago has a large mix of academic, community, and outpatient imaging providers. Ohio contains nationally recognized health systems and high procedure capacity in Cleveland, Columbus, Cincinnati, and other cities. Michigan supports strong demand in Detroit, Grand Rapids, and regional hospital networks. Minnesota is strategically important because of its medtech ecosystem, integrated care models, and advanced imaging expertise.

Wisconsin, Indiana, and Missouri provide stable demand for CT, MRI, digital radiography, ultrasound, mammography, and nuclear imaging. Milwaukee, Madison, Indianapolis, St. Louis, and Kansas City are major procurement centers. These markets are highly attentive to capital discipline and service reliability. Vendors that can demonstrate throughput improvement, lower lifecycle cost, and strong clinical support are well positioned.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller but important markets for rural and regional imaging. Long travel distances and specialist shortages support portable ultrasound, mobile radiography, shared mobile MRI or PET services, and tele-radiology-enabled workflows. Critical access hospitals need dependable systems with manageable infrastructure requirements. Agricultural and energy-sector communities also create demand for trauma and occupational imaging.

The Midwest is expected to grow more slowly than the South and West, but its installed-base replacement opportunity is substantial. Many health systems are modernizing older radiography rooms, expanding outpatient MRI and CT, and standardizing platforms after mergers. The region favors vendors with robust service coverage, financing flexibility, clinical education, and the ability to support both large urban systems and dispersed community hospitals.

Key Market Players

The U.S. Digital Diagnostic Imaging Devices Competitive Landscape is moderately consolidated in premium CT, MRI, nuclear imaging, and enterprise ultrasound, while digital radiography, portable ultrasound, specialty imaging, and point-of-care devices support a broader group of competitors. GE HealthCare, Siemens Healthineers, Philips, Canon Medical, and Fujifilm have the broadest modality portfolios and the largest service footprints. Hologic is highly influential in breast imaging, while United Imaging is expanding as a full-line challenger.

Competition is increasingly platform-based. Leading companies are seeking multi-year fleet agreements that combine equipment, software, upgrades, service, training, and analytics. Buyers prefer vendors that can standardize workflows across sites, maintain uptime, provide cybersecurity support, and offer a credible roadmap for AI and software enhancement. Specialized companies can still gain share by solving a defined problem such as handheld ultrasound, portable MRI, weight-bearing CT, molecular imaging, or 3D breast imaging.

Some of the key players in the U.S. Digital Diagnostic Imaging Devices industry are

GE HealthCare,
Siemens Healthineers,
Philips Healthcare,
Canon Medical Systems USA,
FUJIFILM Healthcare Americas,
Hologic,
United Imaging Healthcare,
Carestream Health,
Samsung Healthcare,
Konica Minolta Healthcare Americas,
Shimadzu Medical Systems USA,
Mindray North America,
Agfa Radiology Solutions,
Butterfly Network,
Hyperfine,
Esaote North America,
Ziehm Imaging,
Planmed,
CurveBeam AI,
Spectrum Dynamics Medical,
QT Imaging,
Delphinus Medical Technologies,
Clarius Mobile Health,
Exo Imaging.

GE HealthCare, Siemens Healthineers, Philips, Canon Medical, and Fujifilm are the strongest broad-based competitors because they combine CT, MRI, X-ray, ultrasound, nuclear imaging, or enterprise workflow capabilities with national service organizations. Hologic leads the premium breast imaging ecosystem. United Imaging competes through high-specification platforms and aggressive value positioning. Carestream, Agfa, Konica Minolta, and Shimadzu are important in digital radiography and selected imaging categories.

Butterfly Network, Clarius, Exo, Mindray, and other portable ultrasound companies are expanding the point-of-care segment. Hyperfine is developing a new category around portable low-field MRI. CurveBeam AI targets weight-bearing extremity CT and orthopedic workflows. Spectrum Dynamics focuses on digital nuclear imaging, while QT Imaging and Delphinus address differentiated breast imaging approaches. The competitive opportunity for these specialists depends on clinical evidence, reimbursement, workflow integration, and the ability to scale training and support.

Market share through 2035 will be influenced by FDA clearances, image quality, installed-base conversion, capital financing, service responsiveness, supply-chain reliability, cybersecurity, AI integration, and health-economic evidence. Companies that can show more exams per day, fewer repeat scans, lower dose or contrast use, reduced staffing burden, and longer upgradeable system life will be best positioned to defend premium pricing.

Recent Developments

Recent developments in the U.S. Digital Diagnostic Imaging Devices Market show a transition toward photon-counting CT, AI-accelerated MRI, software-defined reconstruction, and highly specialized systems. In late 2024, GE HealthCare received FDA clearance for a dedicated 3.0T head-only MRI system designed for advanced neuroimaging and biomarker research. The clearance demonstrated that innovation is extending beyond whole-body platforms into clinically focused systems that can deliver higher performance for specific applications.

Photon-counting CT competition intensified across 2024-2026. Siemens Healthineers expanded its photon-counting portfolio, while GE HealthCare received U.S. clearance in 2026 for its Photonova Spectra systems. These developments signal the beginning of a broader replacement cycle in premium CT. Early adoption will remain concentrated in academic and tertiary centers, but additional configurations and evidence could accelerate diffusion into regional health systems.

MRI sustainability and siting flexibility also advanced. Siemens Healthineers received FDA clearance in early 2026 for a 70-centimeter, virtually helium-free 1.5T MRI platform. Similar low-helium strategies across the industry are becoming relevant to U.S. hospitals because magnet siting, helium exposure, energy use, and lifecycle service have become capital-planning concerns. AI-supported workflow is increasingly packaged with these hardware changes.

Breast imaging continued to evolve through AI and regulatory change. Federal enforcement of updated mammography requirements began in September 2024, including breast-density notification. Hologic expanded its AI-supported mammography capabilities in 2025 with tools designed to prioritize suspicious findings, incorporate prior examinations, and reduce reading time. These developments are pushing breast centers toward integrated imaging, risk, communication, and workflow platforms.

Imaging manufacturers also increased investment in software and enterprise workflow. GE HealthCare completed the acquisition of MIM Software in 2024, strengthening its capabilities in oncology, radiation therapy, molecular imaging, and quantitative image analysis. Across the industry, software acquisitions and partnerships are being used to connect scanners with advanced visualization, AI orchestration, and longitudinal disease management.

Portable and handheld imaging continued to gain regulatory and commercial momentum. FDA clearances for AI-enabled ultrasound measurements, gestational-age support, cardiac assessment, and compact imaging platforms show that point-of-care devices are becoming more clinically structured. Adoption will depend on whether hospitals can build governance, quality assurance, credentialing, and data integration around these devices, but the addressable user base is expanding well beyond radiology departments.

Conclusion

The U.S. Digital Diagnostic Imaging Devices Market Size & Share is positioned to expand from USD 14.90 billion in 2025 to approximately USD 28.63 billion by 2035, supported by a 6.75% CAGR during the forecast period. The market’s long-term strength is grounded in high imaging utilization, a large aging population, cancer and chronic disease burden, replacement of legacy equipment, outpatient expansion, and growing demand for workflow automation.

The most attractive growth opportunities will come from photon-counting and spectral CT, AI-accelerated MRI, digital breast tomosynthesis and breast AI, portable and handheld ultrasound, digital PET, connected mobile radiography, and software-defined upgrades. Mature modalities will remain essential, but revenue growth will increasingly depend on platforms that improve capacity, reduce operator variability, lower dose or contrast use, and provide measurable lifecycle value.

Regional opportunity will be led by the South because of population scale, aging demographics, and hospital expansion. The West will grow fastest because of technology adoption and Mountain West population growth. The Northeast will remain the highest-acuity and most research-intensive market, while the Midwest will provide durable replacement demand and rural-access opportunities. California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, New Jersey, Massachusetts, North Carolina, Georgia, Arizona, Virginia, Michigan, and Minnesota will remain especially important state markets.

For clients evaluating this market, the decisive issue is not simply which modality will grow. The more important questions are which installed fleets are approaching replacement, where imaging capacity is constrained, how AI changes scanner economics, and which vendors can support enterprise standardization. Manufacturers that combine differentiated hardware, upgradeable software, service reliability, cybersecurity, financing, and evidence of workflow improvement will define the next decade of the U.S. digital diagnostic imaging devices industry.

TABLE OF CONTENT

1. U.S. Digital Diagnostic Imaging Devices Market: Market Introduction & Context
1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Digital Diagnostic Imaging Device Manufacturers
1.6.2. Detector, Semiconductor, Magnet, Tube, and Component Suppliers
1.6.3. Hospital Systems and Integrated Delivery Networks
1.6.4. Independent Diagnostic Imaging Centers
1.6.5. Ambulatory, Specialty, and Physician-Owned Imaging Facilities
1.6.6. Group Purchasing Organizations, Distributors, and Equipment Lessors
1.6.7. Radiologists, Technologists, Payers, Regulators, and Clinical Decision-Makers
What this section provides: This section defines the market boundary, study scope, methodology, assumptions, revenue-inclusion criteria, and stakeholder ecosystem so clients understand how the U.S. digital diagnostic imaging devices market is measured and validated.

2. U.S. Digital Diagnostic Imaging Devices Market: Executive Summary
2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, modality-level demand, competitive intensity, and priority investment opportunities.

3. U.S. Digital Diagnostic Imaging Devices Market: Market Dynamics & Outlook
3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Burden of Cancer, Cardiovascular, Neurological, and Musculoskeletal Disorders
3.1.2. Aging Population and Expansion of Screening-Eligible Patient Groups
3.1.3. Replacement of Legacy Analog and Early-Generation Digital Imaging Systems
3.1.4. Growth of Outpatient, Ambulatory, and Decentralized Diagnostic Imaging
3.1.5. AI-Enabled Acquisition, Reconstruction, Workflow Automation, and Decision Support
3.1.6. Hospital Demand for Higher Throughput, Lower Dose, and Improved Asset Utilization
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost and Long Equipment Replacement Cycles
3.2.2. Reimbursement Pressure and Prior-Authorization Requirements
3.2.3. Radiologist and Imaging Technologist Workforce Constraints
3.2.4. Cybersecurity, Interoperability, and Data-Governance Risks
3.2.5. Installation, Shielding, Helium, Power, and Facility-Upgrade Requirements
3.3. Opportunities and Their Impact Analysis
3.3.1. Photon-Counting and Spectral CT Adoption
3.3.2. Helium-Free, Low-Field, and Workflow-Optimized MRI Systems
3.3.3. Portable Digital X-Ray and Point-of-Care Ultrasound Expansion
3.3.4. AI-Enabled Image Reconstruction and Automated Examination Protocols
3.3.5. Digital Breast Tomosynthesis and Contrast-Enhanced Mammography
3.3.6. Hybrid Molecular Imaging and Theranostic Workflow Expansion
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Installed Base, Replacement Cycle, and Equipment Utilization Analysis
What this section provides: This section explains the clinical, economic, reimbursement, workforce, technology, and operational forces shaping demand, helping clients assess both growth potential and execution risk.

4. U.S. Digital Diagnostic Imaging Devices Market: Market Environment & Industry Analysis
4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Modality and Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization, Enterprise Imaging, and Connected Radiology
4.6. Application & Innovation Landscape
4.7. Artificial Intelligence, DICOM, PACS, RIS, and EHR Interoperability Analysis
4.8. FDA Regulatory Framework Analysis
4.9. CMS Reimbursement and Coverage Landscape
4.10. Import/Export Restrictions, Tariff Exposure, and Domestic Sourcing
4.11. Government Screening Initiatives and Public Health Programs
4.12. Impact of Escalating Geopolitical and Semiconductor Supply Tensions
4.13. Hospital Value Analysis Committee and Capital Budget Decision Framework
4.14. Sustainability, Energy Consumption, and Imaging Fleet Decarbonization
What this section provides: This section gives clients a complete view of the external operating environment, including regulation, reimbursement, pricing, digital integration, supply chains, procurement criteria, and sustainability requirements.

5. U.S. Digital Diagnostic Imaging Devices Market – By Product Type
5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Digital X-Ray and Radiography Systems
5.1.2.1. Fixed Digital Radiography Systems
5.1.2.2. Mobile Digital Radiography Systems
5.1.2.3. Digital Fluoroscopy and C-Arm Systems
5.1.2.4. Computed Radiography and Retrofit Detector Systems
5.1.3. Computed Tomography Systems
5.1.3.1. Conventional Multislice CT Systems
5.1.3.2. Spectral and Dual-Energy CT Systems
5.1.3.3. Photon-Counting CT Systems
5.1.3.4. Portable and Specialty CT Systems
5.1.4. Magnetic Resonance Imaging Systems
5.1.4.1. High-Field MRI Systems
5.1.4.2. Mid-Field MRI Systems
5.1.4.3. Low-Field and Ultra-Low-Field MRI Systems
5.1.4.4. Open, Dedicated, and Portable MRI Systems
5.1.5. Diagnostic Ultrasound Systems
5.1.5.1. Cart-Based Ultrasound Systems
5.1.5.2. Compact and Laptop-Based Ultrasound Systems
5.1.5.3. Handheld and Point-of-Care Ultrasound Devices
5.1.5.4. 3D/4D and Specialty Ultrasound Systems
5.1.6. Mammography and Breast Imaging Systems
5.1.6.1. Full-Field Digital Mammography Systems
5.1.6.2. Digital Breast Tomosynthesis Systems
5.1.6.3. Contrast-Enhanced Mammography Systems
5.1.6.4. Dedicated Breast Ultrasound and Supplemental Imaging Systems
5.1.7. Nuclear and Molecular Imaging Systems
5.1.7.1. PET and PET/CT Systems
5.1.7.2. SPECT and SPECT/CT Systems
5.1.7.3. PET/MRI Systems
5.1.7.4. Dedicated Organ-Specific Molecular Imaging Systems
What this section provides: This section identifies the digital imaging modalities and equipment classes expected to generate the largest revenue contribution, fastest replacement demand, and strongest technology-led growth through 2035.

6. U.S. Digital Diagnostic Imaging Devices Market – By Application
6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Oncology Imaging
6.1.2.1. Cancer Screening and Early Detection
6.1.2.2. Tumor Characterization, Staging, and Treatment Planning
6.1.2.3. Therapy Response and Recurrence Monitoring
6.1.3. Cardiovascular Imaging
6.1.3.1. Coronary and Structural Heart Imaging
6.1.3.2. Vascular and Hemodynamic Assessment
6.1.3.3. Image-Guided Cardiac Procedures
6.1.4. Neurology and Neurovascular Imaging
6.1.4.1. Stroke and Emergency Neuroimaging
6.1.4.2. Neurodegenerative and Demyelinating Disease Imaging
6.1.4.3. Brain Tumor and Functional Imaging
6.1.5. Orthopedic and Musculoskeletal Imaging
6.1.5.1. Trauma and Fracture Assessment
6.1.5.2. Spine, Joint, and Soft-Tissue Imaging
6.1.5.3. Sports Medicine and Weight-Bearing Imaging
6.1.6. Women’s Health Imaging
6.1.6.1. Breast Cancer Screening and Diagnostics
6.1.6.2. Obstetric and Gynecologic Imaging
6.1.6.3. Bone Health and Osteoporosis Assessment
6.1.7. Emergency, Pulmonary, Abdominal, and General Diagnostics
6.1.7.1. Emergency and Trauma Imaging
6.1.7.2. Thoracic and Pulmonary Imaging
6.1.7.3. Abdominal, Renal, and Gastrointestinal Imaging
6.1.7.4. Pediatric and General Diagnostic Imaging
What this section provides: This section maps imaging demand to major clinical pathways, helping clients prioritize applications with high examination volumes, screening relevance, reimbursement support, and technology intensity.

7. U.S. Digital Diagnostic Imaging Devices Market – By End User
7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.3. Independent Diagnostic Imaging Centers
7.1.4. Ambulatory Surgery Centers and Outpatient Departments
7.1.5. Specialty Clinics and Physician Practices
7.1.6. Academic Medical Centers and Research Institutions
7.1.7. Emergency, Mobile, Rural, and Community Care Providers
What this section provides: This section explains which care settings and customer groups are expected to drive capital purchases, fleet upgrades, examination volumes, mobile imaging adoption, and recurring technology demand.

8. U.S. Digital Diagnostic Imaging Devices Market – By Technology Type
8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Two-Dimensional Digital Imaging
8.1.3. Three-Dimensional and Four-Dimensional Imaging
8.1.4. Hybrid and Multimodal Imaging
8.1.5. Portable, Mobile, and Point-of-Care Imaging
8.1.6. AI-Enabled and Software-Integrated Imaging
8.1.7. Low-Dose, Spectral, Quantitative, and Functional Imaging
What this section provides: This section evaluates the technology architectures transforming digital imaging performance, including 3D/4D visualization, hybrid modalities, portability, AI automation, dose optimization, and quantitative diagnostics.

9. U.S. Digital Diagnostic Imaging Devices Market – By Procurement Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct OEM and Hospital Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor, Dealer, and Specialty Supplier Sales
9.1.6. Leasing, Managed Equipment Services, and Equipment-as-a-Service
9.1.7. Refurbishment, Retrofit, and Technology Upgrade Programs
What this section provides: This section helps clients understand how U.S. imaging equipment is purchased, financed, standardized, upgraded, and replaced across hospitals, imaging centers, outpatient facilities, and physician practices.

10. U.S. Digital Diagnostic Imaging Devices Market – By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Installed Base, Replacement Cycle, and Imaging Examination Volume Analysis
10.1.4. Regional Hospital, Imaging Center, and Outpatient Infrastructure Analysis
10.1.5. Regional Reimbursement, Capital Budget, and Procurement Dynamics
10.1.6. Regional AI Adoption, Interoperability, and Radiology Workforce Analysis
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Digital Diagnostic Imaging Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Digital Diagnostic Imaging Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Digital Diagnostic Imaging Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Digital Diagnostic Imaging Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, installed-base replacement opportunities, imaging-volume hubs, modality adoption hotspots, procurement structures, and state-level commercial potential.

11. U.S. Digital Diagnostic Imaging Devices Market: Competitive Landscape & Company Profiles
11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. GE HealthCare
11.3.2. Siemens Healthineers
11.3.3. Philips Healthcare
11.3.4. Canon Medical Systems USA
11.3.5. FUJIFILM Healthcare Americas Corporation
11.3.6. Hologic
11.3.7. Carestream Health
11.3.8. Samsung Healthcare
11.3.9. Shimadzu Medical Systems USA
11.3.10. Konica Minolta Healthcare Americas
11.3.11. United Imaging Healthcare
11.3.12. Esaote North America
11.3.13. Mindray North America
11.3.14. Agfa HealthCare
11.3.15. Ziehm Imaging
11.3.16. Planmed USA
11.3.17. NeuroLogica
11.3.18. Butterfly Network
11.3.19. Clarius Mobile Health
11.3.20. EchoNous
11.3.21. Exo Imaging
11.3.22. Nano-X Imaging
11.3.23. CurveBeam AI
11.3.24. Spectrum Dynamics Medical
Note: Each company profile will include company overview, digital diagnostic imaging portfolio, U.S. market strategy, financial positioning, installed-base presence, product pipeline, FDA and regulatory updates, partnerships, service capabilities, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market share visibility, modality-level portfolio positioning, innovation direction, installed-base intelligence, and strategic analysis of major digital diagnostic imaging device companies.

12. U.S. Digital Diagnostic Imaging Devices Market: Future Market Outlook, 2026–2035
12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Photon-Counting and Spectral CT
12.2.2. Helium-Free, Low-Field, and Portable MRI
12.2.3. AI-Enabled Acquisition, Reconstruction, and Workflow Orchestration
12.2.4. Portable Digital Radiography and Handheld Ultrasound
12.2.5. Quantitative, Functional, and Hybrid Molecular Imaging
12.2.6. Digital Twins, Predictive Maintenance, and Remote Fleet Management
12.3. Emerging Business Trends
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Modality Replacement and Upgrade Opportunity Map
What this section provides: This section prepares clients for future technology shifts, replacement cycles, market-structure changes, investment opportunities, and potential adoption scenarios through 2035.

13. U.S. Digital Diagnostic Imaging Devices Market: Strategic Recommendations
13.1. Recommendations for Imaging Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Independent Imaging Centers and Outpatient Providers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors, Dealers, and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. Go-to-Market Strategy Considerations
13.8. Product Positioning, Service Model, and Portfolio Expansion Guidance
13.9. Capital Procurement, Reimbursement, and Clinical Evidence Strategy
What this section provides: This section converts market intelligence into actionable strategy for product development, capital sales, service contracting, channel expansion, investment decisions, reimbursement positioning, and competitive differentiation.

14. U.S. Digital Diagnostic Imaging Devices Market: Disclaimer
14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s limitations, legal boundaries, data-use terms, market-model assumptions, and forecasting constraints.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Digital Diagnostic Imaging Devices Market: Market Definition and Scope
TABLE 3: U.S. Digital Diagnostic Imaging Devices Market: Research Methodology Framework
TABLE 4: U.S. Digital Diagnostic Imaging Devices Market: Key Assumptions
TABLE 5: U.S. Digital Diagnostic Imaging Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Digital Diagnostic Imaging Devices Market: Stakeholder Analysis
TABLE 7: U.S. Digital Diagnostic Imaging Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Digital Diagnostic Imaging Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Digital Diagnostic Imaging Devices Market: Market Attractiveness Index
TABLE 10: U.S. Digital Diagnostic Imaging Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Digital Diagnostic Imaging Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Digital Diagnostic Imaging Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Digital Diagnostic Imaging Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Digital Diagnostic Imaging Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Digital Diagnostic Imaging Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Digital Diagnostic Imaging Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Digital Diagnostic Imaging Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Digital Diagnostic Imaging Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Digital Diagnostic Imaging Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Digital Diagnostic Imaging Devices Market: Installed Base, Replacement Cycle and Equipment Utilization Analysis
TABLE 21: U.S. Digital Diagnostic Imaging Devices Market: PESTEL Analysis
TABLE 22: U.S. Digital Diagnostic Imaging Devices Market: Porter’s Five Forces Analysis
TABLE 23: U.S. Digital Diagnostic Imaging Devices Market: Pricing Trend Analysis by Modality and Region, 2025–2035
TABLE 24: U.S. Digital Diagnostic Imaging Devices Market: Value Chain Analysis
TABLE 25: U.S. Digital Diagnostic Imaging Devices Market: Supply Chain Analysis
TABLE 26: U.S. Digital Diagnostic Imaging Devices Market: Digitalization, Enterprise Imaging and Connected Radiology Impact
TABLE 27: U.S. Digital Diagnostic Imaging Devices Market: Application & Innovation Landscape
TABLE 28: U.S. Digital Diagnostic Imaging Devices Market: AI, DICOM, PACS, RIS and EHR Interoperability Analysis
TABLE 29: U.S. Digital Diagnostic Imaging Devices Market: FDA Regulatory Framework Analysis
TABLE 30: U.S. Digital Diagnostic Imaging Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 31: U.S. Digital Diagnostic Imaging Devices Market: Import/Export Restrictions, Tariff Exposure and Domestic Sourcing
TABLE 32: U.S. Digital Diagnostic Imaging Devices Market: Government Screening Initiatives and Public Health Programs
TABLE 33: U.S. Digital Diagnostic Imaging Devices Market: Geopolitical and Semiconductor Supply Risk Analysis
TABLE 34: U.S. Digital Diagnostic Imaging Devices Market: Hospital Value Analysis Committee and Capital Budget Decision Framework
TABLE 35: U.S. Digital Diagnostic Imaging Devices Market: Sustainability, Energy Consumption and Imaging Fleet Decarbonization
TABLE 36: U.S. Digital Diagnostic Imaging Devices Market: Product Type Snapshot, 2025
TABLE 37: Segment Dashboard; Definition and Scope, by Product Type
TABLE 38: U.S. Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 39: U.S. Digital Diagnostic Imaging Devices Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 40: U.S. Digital Diagnostic Imaging Devices Market: Digital X-Ray and Radiography Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Digital Diagnostic Imaging Devices Market: Computed Tomography Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Digital Diagnostic Imaging Devices Market: Magnetic Resonance Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Digital Diagnostic Imaging Devices Market: Diagnostic Ultrasound Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Digital Diagnostic Imaging Devices Market: Mammography and Breast Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Digital Diagnostic Imaging Devices Market: Nuclear and Molecular Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Digital Diagnostic Imaging Devices Market: Application Snapshot, 2025
TABLE 47: Segment Dashboard; Definition and Scope, by Application
TABLE 48: U.S. Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 49: U.S. Digital Diagnostic Imaging Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 50: U.S. Digital Diagnostic Imaging Devices Market: Oncology Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Digital Diagnostic Imaging Devices Market: Cardiovascular Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Digital Diagnostic Imaging Devices Market: Neurology and Neurovascular Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Digital Diagnostic Imaging Devices Market: Orthopedic and Musculoskeletal Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Digital Diagnostic Imaging Devices Market: Women’s Health Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Digital Diagnostic Imaging Devices Market: Emergency, Pulmonary, Abdominal and General Diagnostics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Digital Diagnostic Imaging Devices Market: End User Snapshot, 2025
TABLE 57: Segment Dashboard; Definition and Scope, by End User
TABLE 58: U.S. Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 59: U.S. Digital Diagnostic Imaging Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 60: U.S. Digital Diagnostic Imaging Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Digital Diagnostic Imaging Devices Market: Independent Diagnostic Imaging Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Digital Diagnostic Imaging Devices Market: Ambulatory Surgery Centers and Outpatient Departments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Digital Diagnostic Imaging Devices Market: Specialty Clinics and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Digital Diagnostic Imaging Devices Market: Academic Medical Centers and Research Institutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Digital Diagnostic Imaging Devices Market: Emergency, Mobile, Rural and Community Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Digital Diagnostic Imaging Devices Market: Technology Type Snapshot, 2025
TABLE 67: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 68: U.S. Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 69: U.S. Digital Diagnostic Imaging Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 70: U.S. Digital Diagnostic Imaging Devices Market: Two-Dimensional Digital Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Digital Diagnostic Imaging Devices Market: Three-Dimensional and Four-Dimensional Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Digital Diagnostic Imaging Devices Market: Hybrid and Multimodal Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Digital Diagnostic Imaging Devices Market: Portable, Mobile and Point-of-Care Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Digital Diagnostic Imaging Devices Market: AI-Enabled and Software-Integrated Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Digital Diagnostic Imaging Devices Market: Low-Dose, Spectral, Quantitative and Functional Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Digital Diagnostic Imaging Devices Market: Procurement Channel Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 78: U.S. Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 79: U.S. Digital Diagnostic Imaging Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 80: U.S. Digital Diagnostic Imaging Devices Market: Direct OEM and Hospital Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Digital Diagnostic Imaging Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Digital Diagnostic Imaging Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Digital Diagnostic Imaging Devices Market: Distributor, Dealer and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Digital Diagnostic Imaging Devices Market: Leasing, Managed Equipment Services and Equipment-as-a-Service Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Digital Diagnostic Imaging Devices Market: Refurbishment, Retrofit and Technology Upgrade Programs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Digital Diagnostic Imaging Devices Market: Regional Snapshot, 2025
TABLE 87: Segment Dashboard; Definition and Scope, by Region
TABLE 88: U.S. Digital Diagnostic Imaging Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 89: U.S. Digital Diagnostic Imaging Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 90: U.S. Digital Diagnostic Imaging Devices Market: Regional Installed Base, Replacement Cycle and Imaging Examination Volume Analysis
TABLE 91: U.S. Digital Diagnostic Imaging Devices Market: Regional Hospital, Imaging Center and Outpatient Infrastructure Analysis
TABLE 92: U.S. Digital Diagnostic Imaging Devices Market: Regional Reimbursement, Capital Budget and Procurement Dynamics
TABLE 93: U.S. Digital Diagnostic Imaging Devices Market: Regional AI Adoption, Interoperability and Radiology Workforce Analysis
TABLE 94: West Region U.S. Digital Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 95: West Region U.S. Digital Diagnostic Imaging Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 96: West Region U.S. Digital Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 99: West Region U.S. Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 100: West Region U.S. Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 102: California Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 103: California Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 104: California Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 105: California Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 106: California Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 107: Washington Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 108: Washington Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 109: Washington Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 110: Washington Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 111: Washington Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 112: Arizona Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 113: Arizona Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 114: Arizona Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 115: Arizona Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 116: Arizona Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 117: Colorado Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 118: Colorado Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 119: Colorado Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 120: Colorado Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 121: Colorado Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 122: Oregon Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 123: Oregon Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 124: Oregon Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 125: Oregon Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 126: Oregon Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 127: Utah Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 128: Utah Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 129: Utah Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 130: Utah Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 131: Utah Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 132: Nevada Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 133: Nevada Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 134: Nevada Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 135: Nevada Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 136: Nevada Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 138: New Mexico Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 139: New Mexico Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 140: New Mexico Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 141: New Mexico Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 142: Idaho Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 143: Idaho Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 144: Idaho Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 145: Idaho Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 146: Idaho Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 147: Montana Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 148: Montana Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 149: Montana Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 150: Montana Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 151: Montana Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 153: Wyoming Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 154: Wyoming Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 155: Wyoming Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 156: Wyoming Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 157: Alaska Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 158: Alaska Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 159: Alaska Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 160: Alaska Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 161: Alaska Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 163: Hawaii Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 164: Hawaii Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 165: Hawaii Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 166: Hawaii Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Digital Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 168: Northeast Region U.S. Digital Diagnostic Imaging Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 169: Northeast Region U.S. Digital Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 171: Northeast Region U.S. Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 172: Northeast Region U.S. Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 173: Northeast Region U.S. Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 174: Northeast Region U.S. Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 175: New York Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 176: New York Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 177: New York Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 178: New York Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 179: New York Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 181: Massachusetts Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 182: Massachusetts Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 183: Massachusetts Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 184: Massachusetts Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 186: New Jersey Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 187: New Jersey Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 188: New Jersey Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 189: New Jersey Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 191: Pennsylvania Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 192: Pennsylvania Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 193: Pennsylvania Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 194: Pennsylvania Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 196: Connecticut Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 197: Connecticut Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 198: Connecticut Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 199: Connecticut Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 200: Maine Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 201: Maine Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 202: Maine Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 203: Maine Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 204: Maine Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 205: Vermont Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 206: Vermont Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 207: Vermont Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 208: Vermont Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 209: Vermont Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 211: New Hampshire Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 212: New Hampshire Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 213: New Hampshire Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 214: New Hampshire Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 216: Rhode Island Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 217: Rhode Island Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 218: Rhode Island Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 219: Rhode Island Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 220: Delaware Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 221: Delaware Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 222: Delaware Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 223: Delaware Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 224: Delaware Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Digital Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 226: South Region U.S. Digital Diagnostic Imaging Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 227: South Region U.S. Digital Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 229: South Region U.S. Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 230: South Region U.S. Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 231: South Region U.S. Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 232: South Region U.S. Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 233: Texas Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 234: Texas Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 235: Texas Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 236: Texas Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 237: Texas Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 238: Florida Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 239: Florida Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 240: Florida Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 241: Florida Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 242: Florida Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 243: Georgia Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 244: Georgia Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 245: Georgia Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 246: Georgia Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 247: Georgia Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 249: North Carolina Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 250: North Carolina Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 251: North Carolina Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 252: North Carolina Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 253: Tennessee Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 254: Tennessee Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 255: Tennessee Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 256: Tennessee Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 257: Tennessee Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 258: South Carolina Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 259: South Carolina Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 260: South Carolina Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 261: South Carolina Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 262: South Carolina Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 263: Alabama Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 264: Alabama Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 265: Alabama Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 266: Alabama Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 267: Alabama Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 268: Mississippi Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 269: Mississippi Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 270: Mississippi Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 271: Mississippi Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 272: Mississippi Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 273: Louisiana Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 274: Louisiana Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 275: Louisiana Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 276: Louisiana Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 277: Louisiana Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 278: Arkansas Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 279: Arkansas Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 280: Arkansas Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 281: Arkansas Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 282: Arkansas Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 283: Kentucky Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 284: Kentucky Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 285: Kentucky Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 286: Kentucky Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 287: Kentucky Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 289: Oklahoma Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 290: Oklahoma Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 291: Oklahoma Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 292: Oklahoma Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 293: Virginia Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 294: Virginia Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 295: Virginia Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 296: Virginia Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 297: Virginia Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 298: Maryland Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 299: Maryland Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 300: Maryland Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 301: Maryland Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 302: Maryland Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 303: West Virginia Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 304: West Virginia Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 305: West Virginia Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 306: West Virginia Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 307: West Virginia Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Digital Diagnostic Imaging Devices Market: Regional Overview and Trends
TABLE 309: Midwest Region U.S. Digital Diagnostic Imaging Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 310: Midwest Region U.S. Digital Diagnostic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 312: Midwest Region U.S. Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 313: Midwest Region U.S. Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 314: Midwest Region U.S. Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 315: Midwest Region U.S. Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 316: Illinois Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 317: Illinois Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 318: Illinois Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 319: Illinois Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 320: Illinois Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 321: Ohio Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 322: Ohio Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 323: Ohio Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 324: Ohio Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 325: Ohio Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 326: Michigan Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 327: Michigan Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 328: Michigan Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 329: Michigan Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 330: Michigan Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 331: Minnesota Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 332: Minnesota Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 333: Minnesota Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 334: Minnesota Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 335: Minnesota Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 336: Indiana Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 337: Indiana Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 338: Indiana Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 339: Indiana Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 340: Indiana Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 342: Wisconsin Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 343: Wisconsin Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 344: Wisconsin Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 345: Wisconsin Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 346: Missouri Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 347: Missouri Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 348: Missouri Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 349: Missouri Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 350: Missouri Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 351: Iowa Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 352: Iowa Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 353: Iowa Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 354: Iowa Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 355: Iowa Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 356: Kansas Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 357: Kansas Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 358: Kansas Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 359: Kansas Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 360: Kansas Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 361: Nebraska Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 362: Nebraska Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 363: Nebraska Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 364: Nebraska Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 365: Nebraska Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 366: North Dakota Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 367: North Dakota Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 368: North Dakota Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 369: North Dakota Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 370: North Dakota Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 371: South Dakota Digital Diagnostic Imaging Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 372: South Dakota Digital Diagnostic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 373: South Dakota Digital Diagnostic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 374: South Dakota Digital Diagnostic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 375: South Dakota Digital Diagnostic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 376: U.S. Digital Diagnostic Imaging Devices Market: Competitive Landscape Snapshot, 2025
TABLE 377: U.S. Digital Diagnostic Imaging Devices Market: Key Company Market Share Analysis, 2025
TABLE 378: U.S. Digital Diagnostic Imaging Devices Market: Company Positioning Matrix
TABLE 379: U.S. Digital Diagnostic Imaging Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 380: U.S. Digital Diagnostic Imaging Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 381: GE HealthCare: Company Profile
TABLE 382: Siemens Healthineers: Company Profile
TABLE 383: Philips Healthcare: Company Profile
TABLE 384: Canon Medical Systems USA: Company Profile
TABLE 385: FUJIFILM Healthcare Americas Corporation: Company Profile
TABLE 386: Hologic: Company Profile
TABLE 387: Carestream Health: Company Profile
TABLE 388: Samsung Healthcare: Company Profile
TABLE 389: Shimadzu Medical Systems USA: Company Profile
TABLE 390: Konica Minolta Healthcare Americas: Company Profile
TABLE 391: United Imaging Healthcare: Company Profile
TABLE 392: Esaote North America: Company Profile
TABLE 393: Mindray North America: Company Profile
TABLE 394: Agfa HealthCare: Company Profile
TABLE 395: Ziehm Imaging: Company Profile
TABLE 396: Planmed USA: Company Profile
TABLE 397: NeuroLogica: Company Profile
TABLE 398: Butterfly Network: Company Profile
TABLE 399: Clarius Mobile Health: Company Profile
TABLE 400: EchoNous: Company Profile
TABLE 401: Exo Imaging: Company Profile
TABLE 402: Nano-X Imaging: Company Profile
TABLE 403: CurveBeam AI: Company Profile
TABLE 404: Spectrum Dynamics Medical: Company Profile
TABLE 405: U.S. Digital Diagnostic Imaging Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 406: U.S. Digital Diagnostic Imaging Devices Market: Disruptive Technologies Impact Matrix
TABLE 407: U.S. Digital Diagnostic Imaging Devices Market: Emerging Business Trends
TABLE 408: U.S. Digital Diagnostic Imaging Devices Market: Business Opportunities for Startups and Existing Players
TABLE 409: U.S. Digital Diagnostic Imaging Devices Market: Investment Prioritization Matrix
TABLE 410: U.S. Digital Diagnostic Imaging Devices Market: Modality Replacement and Upgrade Opportunity Map
TABLE 411: U.S. Digital Diagnostic Imaging Devices Market: Strategic Recommendations for Imaging Device Manufacturers
TABLE 412: U.S. Digital Diagnostic Imaging Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 413: U.S. Digital Diagnostic Imaging Devices Market: Strategic Recommendations for Independent Imaging Centers and Outpatient Providers
TABLE 414: U.S. Digital Diagnostic Imaging Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 415: U.S. Digital Diagnostic Imaging Devices Market: Strategic Recommendations for Distributors, Dealers and Channel Partners
TABLE 416: U.S. Digital Diagnostic Imaging Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 417: U.S. Digital Diagnostic Imaging Devices Market: Go-to-Market Strategy Considerations
TABLE 418: U.S. Digital Diagnostic Imaging Devices Market: Product Positioning, Service Model and Portfolio Expansion Guidance
TABLE 419: U.S. Digital Diagnostic Imaging Devices Market: Capital Procurement, Reimbursement and Clinical Evidence Strategy
TABLE 420: U.S. Digital Diagnostic Imaging Devices Market: Scope Limitation
TABLE 421: U.S. Digital Diagnostic Imaging Devices Market: Data Use Limitation
TABLE 422: U.S. Digital Diagnostic Imaging Devices Market: Forecasting Limitation
TABLE 423: U.S. Digital Diagnostic Imaging Devices Market: Legal Disclaimer
TABLE 424: U.S. Digital Diagnostic Imaging Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Digital Diagnostic Imaging Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: Installed Base, Replacement Cycle and Equipment Utilization Framework
FIGURE 13: U.S. Digital Diagnostic Imaging Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 14: U.S. Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 15: U.S. Digital Diagnostic Imaging Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 16: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 17: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Digital X-Ray and Radiography Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Computed Tomography Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Magnetic Resonance Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Diagnostic Ultrasound Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Mammography and Breast Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Nuclear and Molecular Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Oncology Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Cardiovascular Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Neurology and Neurovascular Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Orthopedic and Musculoskeletal Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Women’s Health Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Emergency, Pulmonary, Abdominal and General Diagnostics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 33: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Independent Diagnostic Imaging Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Ambulatory Surgery Centers and Outpatient Departments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Specialty Clinics and Physician Practices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Academic Medical Centers and Research Institutions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Emergency, Mobile, Rural and Community Care Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Two-Dimensional Digital Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Three-Dimensional and Four-Dimensional Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Hybrid and Multimodal Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Portable, Mobile and Point-of-Care Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: AI-Enabled and Software-Integrated Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Low-Dose, Spectral, Quantitative and Functional Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 49: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Direct OEM and Hospital Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Distributor, Dealer and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Leasing, Managed Equipment Services and Equipment-as-a-Service Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Refurbishment, Retrofit and Technology Upgrade Programs Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 57: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: West Region U.S. Digital Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 59: West Region Market Share Analysis by State, 2025
FIGURE 60: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: California Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Washington Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Arizona Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Colorado Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Oregon Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Utah Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Nevada Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: New Mexico Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Idaho Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Montana Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Wyoming Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Alaska Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Hawaii Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Northeast Region U.S. Digital Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 75: Northeast Region Market Share Analysis by State, 2025
FIGURE 76: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New York Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Massachusetts Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New Jersey Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Pennsylvania Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Connecticut Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Maine Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Vermont Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: New Hampshire Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Rhode Island Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Delaware Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: South Region U.S. Digital Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 88: South Region Market Share Analysis by State, 2025
FIGURE 89: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Texas Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Florida Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Georgia Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: North Carolina Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Tennessee Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: South Carolina Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Alabama Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Mississippi Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Louisiana Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Arkansas Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Kentucky Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Oklahoma Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Virginia Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Maryland Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: West Virginia Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Midwest Region U.S. Digital Diagnostic Imaging Devices Market Share and Leading Players, 2025
FIGURE 106: Midwest Region Market Share Analysis by State, 2025
FIGURE 107: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Illinois Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Ohio Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Michigan Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Minnesota Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Indiana Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Wisconsin Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Missouri Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Iowa Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Kansas Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Nebraska Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: North Dakota Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: South Dakota Digital Diagnostic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 121: Company Positioning Matrix
FIGURE 122: Key Player Product Portfolio Benchmarking
FIGURE 123: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 124: Digital Diagnostic Imaging Innovation Roadmap
FIGURE 125: Photon-Counting and Spectral CT Adoption Roadmap
FIGURE 126: Helium-Free, Low-Field and Portable MRI Opportunity Map
FIGURE 127: AI-Enabled Image Acquisition and Reconstruction Growth Roadmap
FIGURE 128: Portable Digital Radiography and Handheld Ultrasound Adoption Roadmap
FIGURE 129: Hybrid Molecular Imaging and Theranostics Opportunity Map
FIGURE 130: Future Market Scenario Analysis, 2026–2035
FIGURE 131: Disruptive Technologies Impact Matrix
FIGURE 132: Emerging Business Trends Matrix
FIGURE 133: Investment Prioritization Matrix
FIGURE 134: Modality Replacement and Upgrade Opportunity Map
FIGURE 135: Strategic Growth Roadmap for U.S. Digital Diagnostic Imaging Device Companies
FIGURE 136: Go-to-Market Strategy Framework
FIGURE 137: Product Positioning, Service Model and Portfolio Expansion Framework
FIGURE 138: Capital Procurement, Reimbursement and Clinical Evidence Strategy Framework
FIGURE 139: Report Scope and Disclaimer Framework